About this trial
Aim of the proposal is to create an interactive AI-based multicentre prospective database to provide information on how to improve the QoC for pts with HF.This will provide detailed information on pts characteristics,treatment practices, adherence to prescribed guideline-based optimal drug therapy,and outcomes.The database stems from a registry started two years ago,conceived to provide a contemporary snapshot on the adherence to the latest European GGLL for the therapeutic management of pts with HF.The database will be integrated with a specifically designed algorithm that provides an accurate feedback on whether patients are properly treated according to the ESC most recent recommendations.The expected outcomes are:-define non-adherence level to GGLL-based recommendations for treatment of HF;-provide information on initiation, adherence and persistence over time of the recommended treatment;-reduce medical inertia;produce practical implications to reduce morbidity and mortality
Eligibility criteria
Qualifiers
Both gender
Age >18 years
Signed informed consent for the study
Known diagnosis of heart failure > 6 months
Disqualifiers
Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons
Concurrent diagnosis of neoplasia
Advanced COPD (FEV1 <50%)
Advanced valvular heart disease (severe mitral-aortic stenosis-insufficiency requiring cardiac surgery)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
IRCCS San Raffaele Roma
Lead sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborator
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
Collaborator